Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3859 ARTÍCULOS , VIENDO DEL 3826 AL 3840

Novel C1A Domain Variant in Protein Kinase Cγ in Spinocerebellar Ataxia Type 14 Decreases Autoinhibition

Raj Ghosh G, Kao TH, Steigerwald CG, Chan NL, Newton AC, Abreu NJ.

Cerebellum. 2025 Mar 18;24(3):65. doi: 10.1007/s12311-025-01818-x.

Post-COVID Myoclonus-Ataxia Syndrome: A Case Report of Successful Recovery With Intravenous Immunoglobulin (IVIG) Treatment

Babar M, Arain A, Hamide A, Rashid R.

Cureus. 2025 Nov 13;17(11):e96796. doi: 10.7759/cureus.96796. eCollection 2025 Nov.

Paraneoplastic KLHL11 encephalitis presenting with progressive tinnitus, hearing loss and ataxia

Mahmoud A, Dubey D, Goonetilleke A, Lee G, Elhabet S, Ahmad I, Dogar M, Jacob A.

Pract Neurol. 2025 Sep 12;25(5):443-447. doi: 10.1136/pn-2024-004498.

A Novel Myoclonus-Ataxic Presentation of Chronic Lead Toxicity

Holla VV, Sharma P, Kamble N, Yadav R, Pal PK.

Mov Disord Clin Pract. 2025 Aug;12 Suppl 2(Suppl 2):S7-S9. doi: 10.1002/mdc3.70024. Epub 2025 Feb 27.

Adult-onset opsoclonus-myoclonus-ataxia syndrome accompanying an infection with tick-borne encephalitis virus: A case report

Nožić Škerjanec T, Berlot R.

Acta Neurol Belg. 2025 Oct;125(5):1437-1439. doi: 10.1007/s13760-025-02820-0. Epub 2025 Jun 13.

Anti-GFAP associated opsoclonus-myoclonus-ataxia syndrome in a patient with multiple autoimmune comorbidities-a case report

Sørensen NV, Nilsson AC, Dos AH, Stenør CM.

J Neurol. 2025 Mar 12;272(4):263. doi: 10.1007/s00415-025-12999-0.

Opsoclonus-myoclonus-ataxia Syndrome in an ART-naïve Patient With CSF/Plasma HIV-1 RNA Discordance

Matsuo H, Yonekura K, Kutsuna S.

Open Forum Infect Dis. 2025 Aug 21;12(9):ofaf517. doi: 10.1093/ofid/ofaf517. eCollection 2025 Sep.

Clinical Reasoning: A 38-Year-Old Man With Involuntary Jerk-Like Movements and Ataxia

Gomez AC, Charra Castellani MB, Kurtz V, García Tascón G, Garino E, Knorre E, Ballesteros D.

Neurology. 2025 Nov 25;105(10):e214381. doi: 10.1212/WNL.0000000000214381. Epub 2025 Oct 23.

Myoclonus dystonia as a predominant manifestation in ataxia telangiectasia

Carvalho M, Mehta S, Singh J, Lal V.

Neurol Sci. 2025 May;46(5):2325-2327. doi: 10.1007/s10072-024-07923-9. Epub 2024 Dec 11.

Anti-dipeptidyl-peptidase-like protein-6 (DPPX) autoimmune encephalitis associated with severe multifocal dystonia

Roddy E, Gentry E, Holiday V, Robertson D, Hedera P.

Clin Park Relat Disord. 2025 Apr 2;12:100320. doi: 10.1016/j.prdoa.2025.100320. eCollection 2025.

Seronegative Paraneoplastic Opsoclonus-Myoclonus-Ataxia Syndrome Secondary to Low Volume Endocrine-Sensitive Malignancy of Likely Breast Origin

Berger G, Jackson-Tarlton C, Rayson D, Silver A, Walsh M, Drohan A.

Curr Oncol. 2025 Aug 6;32(8):440. doi: 10.3390/curroncol32080440.

Movement Disorders in West Nile Virus Infection: A Systematic Review of Reported Cases and Conference Abstracts

Garg RK, Pandey S, Singhal S.

Mov Disord Clin Pract. 2026 May;13(5):1180-1186. doi: 10.1002/mdc3.70417. Epub 2025 Nov 1.

Case Report: Compound heterozygous KCTD7 variants in two siblings presenting with myoclonic epilepsy and ataxia

Song J, Wu W, Tian Y, Qin L, Wei S, Yu B, Su H, Huang L, Liu W, Huang X.

Front Neurosci. 2025 Nov 12;19:1670008. doi: 10.3389/fnins.2025.1670008. eCollection 2025.

Zellweger spectrum disorder presenting with opsoclonus-myoclonus-ataxia syndrome: a case report on immunotherapy

Kılıç M, Yıldız H, Konuskan B.

Acta Neurol Belg. 2025 Jun;125(3):861-864. doi: 10.1007/s13760-025-02724-z. Epub 2025 Jan 18.

Enterovirus A-71 Associated Parainfectious Movement Disorders in Children

van Noort SAM, Elting JWJ, Foiadelli T, Peters PJJS, Nicolai J, Tijssen MAJ, Helfferich J.

Mov Disord Clin Pract. 2025 Oct;12(10):1635-1639. doi: 10.1002/mdc3.70182. Epub 2025 Jun 18.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias